Pembrolizumab plus chemotherapy in triple-negative breast cancer – Authors' reply. Issue 10294 (3rd July 2021)

Record Type:: Journal Article
Title:: Pembrolizumab plus chemotherapy in triple-negative breast cancer – Authors' reply. Issue 10294 (3rd July 2021)
Main Title:: Pembrolizumab plus chemotherapy in triple-negative breast cancer – Authors' reply
Authors:: Cortes, Javier
Rugo, Hope S
Guo, Zifang
Karantza, Vassiliki
Schmid, Peter
Abstract:
Is Part Of:: Lancet. Volume 398:Issue 10294(2021)
Journal:: Lancet
Issue:: Volume 398:Issue 10294(2021)
Issue Display:: Volume 398, Issue 10294 (2021)
Year:: 2021
Volume:: 398
Issue:: 10294
Issue Sort Value:: 2021-0398-10294-0000
Page Start:: 24
Page End:: 25
Publication Date:: 2021-07-03
Subjects:: Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Medicine
Electronic journals
Periodicals
610.5
Journal URLs:: http://www.thelancet.com/ ↗
http://www.sciencedirect.com/science/journal/01406736 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0140-6736(21)00374-3 ↗
Languages:: English
ISSNs:: 0140-6736
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5146.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 17622.xml